Literature DB >> 27451347

Factors associated with failure of emergency department management in children with acute moderate or severe asthma: a prospective, multicentre, cohort study.

Francine M Ducharme1, Roger Zemek2, Bhupendrasinh F Chauhan3, Jocelyn Gravel4, Dominic Chalut5, Naveen Poonai6, Marie-Claude Guertin7, Caroline Quach8, Lucie Blondeau7, Sophie Laberge9.   

Abstract

BACKGROUND: The management of paediatric asthma exacerbations is based on trials in children of all ages. Recent studies from 2009 raised the possibility that preschoolers (younger than 6 years) with viral-induced wheezing and children exposed to tobacco smoke might be at an increased risk of treatment failure. The study objective was to identify factors associated with management failure in children presenting to the emergency department with moderate or severe asthma exacerbations.
METHODS: We undertook a prospective, multicentre cohort study of children aged 1-17 years presenting to five emergency departments with moderate or severe asthma (defined as a Pediatric Respiratory Assessment Measure [PRAM] of 4 to 12). Children received oral corticosteroids and severity-specific inhaled bronchodilator therapy. The primary outcome was emergency department management failure (hospital admission, prolonged emergency department therapy [≥8 h], or relapse within 72 h of discharge from the emergency department with admission to hospital or prolonged emergency department stay). Viral cause was ascertained by PCR on nasopharyngeal specimens and environmental tobacco smoke exposure by salivary cotinine concentration. This study is registered at ClinicalTrials.gov (NCT02013076).
FINDINGS: Between Feb 14, 2011, and Dec 20, 2013, we screened 1893 children and enrolled 1012 eligible children. Of those eligible children, 973 participants were included in the analysis. 165 (17%) of 965 children experienced management failure in the emergency department, which was significantly associated with viral detection (110 [19%] of 579 participants with virus detection vs 46 [13%] of 354 participants without viral detection, odds ratio [OR] 1·57; 95% CI 1·04-2·37), fever (24% vs 15%, 1·96; 1·32-2·92), baseline PRAM (OR 1·38 per 1-point increase; 1·22-1·56), oxygen saturation of less than 92% (50% vs 12%, 3·94; 1·97-7·89), and presence of symptoms between exacerbations (21% vs 16%, 1·73; 1·13-2·64). Age, salivary cotinine concentration, and oral corticosteroids dose were not significantly associated with management failure. Viral detection (67% vs 46%, p<0·0001) and fever (31% vs 16%, p<0·0001) occurred more frequently in preschoolers than in older children. Viral detection was also associated with reduced speed of recovery over the 10 days after discharge.
INTERPRETATION: In children presenting with moderate or severe asthma, viral detection, but not age, was associated with failure of symptom management, independently from exacerbation severity (ie, baseline PRAM and oxygen saturation), fever, and symptom chronicity (viral detection). Although it did not reach statistical significance, the association between treatment management failure and exposure to tobacco smoke warrants further investigation. FUNDING: Canadian Institutes of Health Research. Copyright Â
© 2016 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27451347     DOI: 10.1016/S2213-2600(16)30160-6

Source DB:  PubMed          Journal:  Lancet Respir Med        ISSN: 2213-2600            Impact factor:   30.700


  10 in total

Review 1.  Chinese expert consensus-based guideline on assessment and management of asthma exacerbation.

Authors:  Jiangtao Lin; Bin Xing; Ping Chen; Mao Huang; Xin Zhou; Changgui Wu; Dong Yang; Kaisheng Yin; Shaoxi Cai; Xiaoming Cheng; Chuangli Hao; Changzheng Wang; Chuntao Liu
Journal:  J Thorac Dis       Date:  2019-12       Impact factor: 2.895

2.  Risk factors for intensive care admission in children with severe acute asthma in the Netherlands: a prospective multicentre study.

Authors:  Shelley A Boeschoten; Annemie L Boehmer; Peter J Merkus; Joost van Rosmalen; Johan C de Jongste; Pieter L A Fraaij; Richard Molenkamp; Sabien G Heisterkamp; Job B van Woensel; Berber Kapitein; Eric G Haarman; Roelie M Wösten-van Asperen; Martin C Kneyber; Joris Lemson; Stan Hartman; Dick A van Waardenburg; Heleen E Bunker-Wiersma; Carole N Brouwer; Bart E van Ewijk; Anneke M Landstra; Mariel Verwaal; Anja A Vaessen-Verberne; Sanne Hammer; Corinne M Buysse; Matthijs de Hoog
Journal:  ERJ Open Res       Date:  2020-08-17

3.  Association of secondhand smoke exposure with asthma symptoms, medication use, and healthcare utilization among asthmatic adolescents.

Authors:  Ashley L Merianos; Roman A Jandarov; E Melinda Mahabee-Gittens
Journal:  J Asthma       Date:  2018-05-01       Impact factor: 2.515

4.  Severe childhood asthma exacerbations: Is treatment response variability in the genes?

Authors:  Monica Tang; Kanecia O Zimmerman; Jason E Lang
Journal:  Pediatr Pulmonol       Date:  2019-03-13

Review 5.  Vitamin D and Immunity in Infants and Children.

Authors:  Geneviève Mailhot; John H White
Journal:  Nutrients       Date:  2020-04-27       Impact factor: 5.717

6.  Influence of viral infection on the relationships between airway cytokines and lung function in asthmatic children.

Authors:  Toby C Lewis; Ediri E Metitiri; Graciela B Mentz; Xiaodan Ren; Ashley R Carpenter; Adam M Goldsmith; Kyra E Wicklund; Breanna N Eder; Adam T Comstock; Jeannette M Ricci; Sean R Brennan; Ginger L Washington; Kendall B Owens; Bhramar Mukherjee; Thomas G Robins; Stuart A Batterman; Marc B Hershenson
Journal:  Respir Res       Date:  2018-11-21

7.  Does atopy affect the course of viral pneumonia?

Authors:  S B Erdem; D Can; S Girit; F Çatal; V Şen; S Pekcan; H Yüksel; A Bingöl; I Bostancı; D Erge; R Ersu
Journal:  Allergol Immunopathol (Madr)       Date:  2017-06-17       Impact factor: 1.667

8.  Azithromycin and high-dose vitamin D for treatment and prevention of asthma-like episodes in hospitalised preschool children: study protocol for a combined double-blind randomised controlled trial.

Authors:  Julie Nyholm Kyvsgaard; Ulrik Ralfkiaer; Nilofar Følsgaard; Trine Mølbæk Jensen; Laura Marie Hesselberg; Ann-Marie M Schoos; Klaus Bønnelykke; Hans Bisgaard; Jakob Stokholm; Bo Chawes
Journal:  BMJ Open       Date:  2022-04-13       Impact factor: 2.692

9.  Vitamin D in the prevention of exacerbations of asthma in preschoolers (DIVA): protocol for a multicentre randomised placebo-controlled triple-blind trial.

Authors:  Megan E Jensen; Francine M Ducharme; Nathalie Alos; Geneviève Mailhot; Benoît Mâsse; John H White; Mohsen Sadatsafavi; Ali Khamessan; Sze Man Tse; Reza Alizadehfar; Dirk E Bock; Patrick Daigneault; Chantal Lemire; Connie Yang; Dhenuka Radhakrishnan
Journal:  BMJ Open       Date:  2019-12-30       Impact factor: 2.692

10.  Association Between Intravenous Magnesium Therapy in the Emergency Department and Subsequent Hospitalization Among Pediatric Patients With Refractory Acute Asthma: Secondary Analysis of a Randomized Clinical Trial.

Authors:  Suzanne Schuh; Stephen B Freedman; Roger Zemek; Amy C Plint; David W Johnson; Francine Ducharme; Jocelyn Gravel; Graham Thompson; Sarah Curtis; Derek Stephens; Allan L Coates; Karen J Black; Darcy Beer; Judy Sweeney; Maggie Rumantir; Yaron Finkelstein
Journal:  JAMA Netw Open       Date:  2021-07-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.